Cargando…
Prognostic implications of combined high expression of CD47 and MCT1 in breast cancer: a retrospective study during a 10-year period
BACKGROUND: Clinical outcome after surgery of breast cancer needs more prognostic markers to predict currently. Cluster of differentiation 47 (CD47), due to its overexpression in various tumors and ability to inhibit phagocytosis, has been identified as a new immune checkpoint. Monocarboxylate trans...
Autores principales: | Sun, Yanting, Liang, Shujing, Li, Tong, Peng, Chujie, Yang, Yiting, Lin, Yun, Ma, Yabin, Dong, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841544/ https://www.ncbi.nlm.nih.gov/pubmed/35261882 http://dx.doi.org/10.21037/tcr-21-1951 |
Ejemplares similares
-
Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021) -
Evaluation of MCT1, MCT4 and CD147 Genes in Peripheral Blood Cells of Breast Cancer Patients and Their Potential Use as Diagnostic and Prognostic Markers
por: Luz, Maria Cláudia de B., et al.
Publicado: (2017) -
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
por: Bovenzi, Cory D., et al.
Publicado: (2015) -
Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases
por: Liu, Jiayong, et al.
Publicado: (2020) -
MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
por: Fisel, Pascale, et al.
Publicado: (2015)